We’re proud to share that Dr. Barry Drees, the founder of TriloDocs and the brilliant mind behind our rule-based AI—which applies expert medical writing knowledge to ensure unmatched data accuracy—has rejoined TriloDocs as an Advisor.
Barry’s return comes at a pivotal moment as we expand and refine our product offerings post-integration into the Genactis family. His guidance will be instrumental in ensuring that TriloDocs remains the most accurate and reliable medical writing AI solution in the global market.
With a PhD in Molecular Genetics from the University of California and postdoctoral research funded by the U.S. NIH, Barry brings deep scientific insight and decades of industry experience to the table. He is a former EMWA President and past Editor-in-Chief of the EMWA journal, and continues to be a respected thought leader in the field.
We’re thrilled to have him back and helping to shape what’s next for TriloDocs.
By
·
1 minute read